Brian Blakey
Corporate Officer/Principal at STEALTH BIOTHERAPEUTICS CORP
Active connections
| Name | Gender | Age | Linked companies | Collaboration |
|---|---|---|---|---|
| Irene P. McCarthy | F | 59 |
Stealth BioTherapeutics, Inc.
 Stealth BioTherapeutics, Inc. Pharmaceuticals: MajorHealth Technology Part of Stealth BioTherapeutics Corp., Stealth BioTherapeutics, Inc. develops therapies to treat mitochondrial dysfunctions and age-related diseases. The private company is based in Newton, MA. The company was founded in 2007. Irene P. McCarthy has been the CEO of the company since 2009. | 15 years |
| Martin Redmon | M | 62 |
Stealth BioTherapeutics, Inc.
Stealth BioTherapeutics, Inc. Pharmaceuticals: MajorHealth Technology Part of Stealth BioTherapeutics Corp., Stealth BioTherapeutics, Inc. develops therapies to treat mitochondrial dysfunctions and age-related diseases. The private company is based in Newton, MA. The company was founded in 2007. Irene P. McCarthy has been the CEO of the company since 2009. | - |
| Kevin McLaughlin | M | 67 |
Stealth BioTherapeutics, Inc.
Stealth BioTherapeutics, Inc. Pharmaceuticals: MajorHealth Technology Part of Stealth BioTherapeutics Corp., Stealth BioTherapeutics, Inc. develops therapies to treat mitochondrial dysfunctions and age-related diseases. The private company is based in Newton, MA. The company was founded in 2007. Irene P. McCarthy has been the CEO of the company since 2009. | 7 years |
| Edward Owens | M | 77 |
Stealth BioTherapeutics, Inc.
Stealth BioTherapeutics, Inc. Pharmaceuticals: MajorHealth Technology Part of Stealth BioTherapeutics Corp., Stealth BioTherapeutics, Inc. develops therapies to treat mitochondrial dysfunctions and age-related diseases. The private company is based in Newton, MA. The company was founded in 2007. Irene P. McCarthy has been the CEO of the company since 2009. | 7 years |
| Francis Chen | M | 75 |
Stealth BioTherapeutics, Inc.
Stealth BioTherapeutics, Inc. Pharmaceuticals: MajorHealth Technology Part of Stealth BioTherapeutics Corp., Stealth BioTherapeutics, Inc. develops therapies to treat mitochondrial dysfunctions and age-related diseases. The private company is based in Newton, MA. The company was founded in 2007. Irene P. McCarthy has been the CEO of the company since 2009. | 18 years |
| Lok Chung Chan | M | 73 |
Stealth BioTherapeutics, Inc.
Stealth BioTherapeutics, Inc. Pharmaceuticals: MajorHealth Technology Part of Stealth BioTherapeutics Corp., Stealth BioTherapeutics, Inc. develops therapies to treat mitochondrial dysfunctions and age-related diseases. The private company is based in Newton, MA. The company was founded in 2007. Irene P. McCarthy has been the CEO of the company since 2009. | 17 years |
| Robert Weiskopf | M | 73 |
Stealth BioTherapeutics, Inc.
Stealth BioTherapeutics, Inc. Pharmaceuticals: MajorHealth Technology Part of Stealth BioTherapeutics Corp., Stealth BioTherapeutics, Inc. develops therapies to treat mitochondrial dysfunctions and age-related diseases. The private company is based in Newton, MA. The company was founded in 2007. Irene P. McCarthy has been the CEO of the company since 2009. | 5 years |
| Eve Elizabeth Slater | M | 78 | 4 years | |
| Henry H. Hess | M | 51 | 13 years | |
| Louis Lange | M | 72 | 5 years | |
| Reenie McCarthy | F | - |
Stealth BioTherapeutics, Inc.
Stealth BioTherapeutics, Inc. Pharmaceuticals: MajorHealth Technology Part of Stealth BioTherapeutics Corp., Stealth BioTherapeutics, Inc. develops therapies to treat mitochondrial dysfunctions and age-related diseases. The private company is based in Newton, MA. The company was founded in 2007. Irene P. McCarthy has been the CEO of the company since 2009. | - |
| James R. Carr | M | 61 | 10 years | |
| Sally Jackson | F | - | 23 years | |
| Janhavi Mohite | F | - | - | |
| Amelia Stetler | F | - | - | |
| Brian Hotchkiss | M | - | - | |
| Mike Malynn | M | - | - | |
| Anthony Walsh | M | - | 2 years | |
| Timothy Woodthorpe | M | - | 24 years |
Connections Chart
Multi-company connection
Former connections
| Name | Gender | Age | Linked companies | Collaboration |
|---|---|---|---|---|
| Russell Medford | M | 69 |
AtheroGenics, Inc.
 AtheroGenics, Inc. Pharmaceuticals: MajorHealth Technology AtheroGenics is a pharmaceutical company focused on the discovery, development and commercialization of novel drugs for the treatment of chronic inflammatory diseases, such as atherosclerosis, asthma and arthritis. | 16 years |
| Charles Deignan | M | 59 |
AtheroGenics, Inc.
AtheroGenics, Inc. Pharmaceuticals: MajorHealth Technology AtheroGenics is a pharmaceutical company focused on the discovery, development and commercialization of novel drugs for the treatment of chronic inflammatory diseases, such as atherosclerosis, asthma and arthritis. | 10 years |
| Mark P. Colonnese | M | 68 |
AtheroGenics, Inc.
AtheroGenics, Inc. Pharmaceuticals: MajorHealth Technology AtheroGenics is a pharmaceutical company focused on the discovery, development and commercialization of novel drugs for the treatment of chronic inflammatory diseases, such as atherosclerosis, asthma and arthritis. | 12 years |
| Alan Levine | M | 63 |
University of Florida
| 7 years |
| Mike Bain | M | - |
University of Florida
| 6 years |
| Julian Heslop | M | 70 | 13 years | |
| Louis Vincent Sicilian | M | - |
University of Florida
| 5 years |
| Ping Sung Wu | M | - |
University of Florida
| 5 years |
| Keith Jeffrey Blum | M | - |
University of Florida
| 5 years |
| Elizabeth T. Wilkinson | F | 66 |
University of Florida
| 3 years |
| Dan Rice | M | 61 |
University of Florida
| 5 years |
| David R. Punzak | M | - |
University of Florida
| 7 years |
| Crispin Davis | M | 75 | 10 years | |
| Gex Franklin Richardson | M | 59 |
University of Florida
| 6 years |
| Krishna Memani | M | - |
University of Florida
| 3 years |
| Walid Wael Ayoub Zurub | M | 57 |
University of Florida
| 5 years |
| Mark Cosola | M | - |
University of Florida
| 6 years |
| Cheuk Kin Law | M | 61 | 1 years | |
| Chirag Bhavsar | M | 55 |
University of Florida
| 5 years |
| John Morgan | M | 68 |
University of Florida
| 8 years |
| Murray Stewart | M | 63 | 17 years | |
| Mehdi Hosseini | M | - |
University of Florida
| 5 years |
| Terry Delahunty | M | - |
University of Florida
| 10 years |
| John David Coombe | M | 79 | 5 years | |
| Steve K. Mergler | M | - |
University of Florida
| 7 years |
| Richard Sykes | M | 79 | 7 years | |
| H. Culp | M | 60 | 9 years | |
| Joseph Gaynor | M | 63 |
AtheroGenics, Inc.
AtheroGenics, Inc. Pharmaceuticals: MajorHealth Technology AtheroGenics is a pharmaceutical company focused on the discovery, development and commercialization of novel drugs for the treatment of chronic inflammatory diseases, such as atherosclerosis, asthma and arthritis. | 14 years |
| R. Wayne Alexander | M | 83 |
AtheroGenics, Inc.
AtheroGenics, Inc. Pharmaceuticals: MajorHealth Technology AtheroGenics is a pharmaceutical company focused on the discovery, development and commercialization of novel drugs for the treatment of chronic inflammatory diseases, such as atherosclerosis, asthma and arthritis. | 16 years |
| Peter Traber | M | 69 | 3 years | |
| Jean-Pierre Garnier | M | 75 | 8 years | |
| Robert Scott | M | 70 |
AtheroGenics, Inc.
AtheroGenics, Inc. Pharmaceuticals: MajorHealth Technology AtheroGenics is a pharmaceutical company focused on the discovery, development and commercialization of novel drugs for the treatment of chronic inflammatory diseases, such as atherosclerosis, asthma and arthritis. | 6 years |
| Ian Maurice Gray Prosser | M | 81 | 9 years | |
| Robert Wilson | M | 81 | 11 years | |
| William A. Lawrence | M | 64 |
University of Florida
| 6 years |
| Margaret E. Grayson | F | 77 |
AtheroGenics, Inc.
AtheroGenics, Inc. Pharmaceuticals: MajorHealth Technology AtheroGenics is a pharmaceutical company focused on the discovery, development and commercialization of novel drugs for the treatment of chronic inflammatory diseases, such as atherosclerosis, asthma and arthritis. | 3 years |
| Ronald N. Rosenwasser | M | 63 |
University of Florida
| 3 years |
| Keith Alexander | M | - |
University of Florida
| 4 years |
| Kamil Engin Yesil | M | 62 |
University of Florida
| 4 years |
| Deborah Fasanelli | F | 58 |
University of Florida
| 4 years |
| David B. Pfeil | M | - |
University of Florida
| 4 years |
| John M. Duich | M | 69 |
University of Florida
| 4 years |
| Paul D. DeStefanis | M | 63 |
University of Florida
| 4 years |
| Lep G. Adams | M | - |
University of Florida
| 3 years |
| John F. Panzarella | M | - |
University of Florida
| 4 years |
| Wasim Wael Ayoub Zurub | M | 54 |
University of Florida
| 4 years |
| Monica A. B. Murphy | F | - |
University of Florida
| 3 years |
| Brad Ridinger | M | - |
University of Florida
| 4 years |
| Hani Abdul Rahman Mustafa Al-Ali | M | 59 |
University of Florida
| 4 years |
| Harold Talisman | M | - |
University of Florida
| 4 years |
| Geoffrey Allen Frazier | M | - |
University of Florida
| 4 years |
| Kay Lucas | F | - |
University of Florida
| 4 years |
| Gene Connelly | M | - |
University of Florida
| 4 years |
| Jillian Marcus | F | - |
University of Florida
| 4 years |
| Harry L. Chisholm | M | - |
University of Florida
| 5 years |
| William Toreki | M | - |
University of Florida
| 3 years |
| D. Paul Brockmiller | M | - |
University of Florida
| 4 years |
| Peyvand M. Khademi | M | - |
University of Florida
| 4 years |
| Mark T. Evans | M | - |
University of Florida
| 4 years |
| Brad Donovan | M | - |
University of Florida
| 4 years |
| Jerrold A. Wish | M | - |
University of Florida
| 3 years |
| R. Bruce Christmas | M | - |
University of Florida
| 4 years |
| Bob Meeder | M | 63 |
University of Florida
| - |
| Scott Renner | M | 55 |
University of Florida
| 4 years |
| Meade Owens | F | - |
University of Florida
| 4 years |
| Dean Saunders | M | 63 |
University of Florida
| 4 years |
| Alan G. Merten | M | 83 |
University of Florida
| 3 years |
| Ken C. Murray | M | - |
University of Florida
| 4 years |
| Thomas A. Geoffroy | M | - |
University of Florida
| 4 years |
| Brad Hathorn | M | - |
University of Florida
| 4 years |
| David Miller Blount | M | 62 |
University of Florida
| 4 years |
| Shari Costantini | F | - |
University of Florida
| 4 years |
| Cindy New | F | - |
University of Florida
| 4 years |
| Wei Li Chen | M | - |
University of Florida
| 4 years |
| Stephen Marshall | M | - |
University of Florida
| 1 years |
| James Robinson | M | 95 |
University of Florida
| 2 years |
| Lundy Richard Wright | M | - |
University of Florida
| 4 years |
| John Teegen | M | - |
University of Florida
| 4 years |
| James R. Hagy | M | - |
University of Florida
| 5 years |
| Robert H. Weinstein | M | - |
University of Florida
| 4 years |
| Brian Shutts | M | - |
University of Florida
| 4 years |
Statistics
| Country | Connections | % of total |
|---|---|---|
| United States | 88 | 88.00% |
| United Kingdom | 12 | 12.00% |
Age of Connections
Active
Past
Male
Female
Members of the board
Executives
Origin of connections
- Stock Market
- Insiders
- Brian Blakey
- Personal Network
